Stifel’s medical technology team recently visited with three top companies in their coverage universe.
Stifel’s medical technology team recently visited with three top companies in their coverage universe. All three are leaders in the specific med-tech silos they occupy and are acknowledged by most on Wall Street as the preeminent firms in their space. The analysts have updated their research on the companies, and all remain Buy rated. While better suited for aggressive growth accounts, they all could supply strong alpha performance in 2018. They are: Align Technology, Edwards Lifesciences, and Intuitive Surgical.
